{
    "title": "To amend the Internal Revenue Code of 1986 to encourage charitable contributions to public charities for use in medical research.",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Medical Research Investment Act of \n2001''.\n\nSEC. 2. INCREASE IN LIMITATION ON CHARITABLE DEDUCTION FOR \n              CONTRIBUTIONS FOR MEDICAL RESEARCH.\n\n    (a) In General.--Paragraph (1) of section 170(b) of the Internal \nRevenue Code of 1986 (relating to percentage limitations) is amended by \nadding at the end the following new subparagraph:\n                    ``(G) Special limitation with respect to certain \n                contributions for medical research.--\n                            ``(i) In general.--Any medical research \n                        contribution shall be allowed to the extent \n                        that the aggregate of such contributions does \n                        not exceed the lesser of--\n                                    ``(I) 80 percent of the taxpayer's \n                                contribution base for any taxable year, \n                                or\n                                    ``(II) the excess of 80 percent of \n                                the taxpayer's contribution base for \n                                the taxable year over the amount of \n                                charitable contributions allowable \n                                under subparagraphs (A) and (B) \n                                (determined without regard to \n                                subparagraph (C)).\n                            ``(ii) Carryover.--If the aggregate amount \n                        of contributions described in clause (i) \n                        exceeds the limitation of such clause, such \n                        excess shall be treated (in a manner consistent \n                        with the rules of subsection (d)(1)) as a \n                        medical research contribution in each of the 10 \n                        succeeding taxable years in order of time.\n                            ``(iii) Treatment of capital gain \n                        property.--In the case of any medical research \n                        contribution of capital gain property (as \n                        defined in subparagraph (C)(iv)), subsection \n                        (e)(1) shall apply to such contribution.\n                            ``(iv) Medical research contribution.--For \n                        purposes of this subparagraph, the term \n                        `medical research contribution' means a \n                        charitable contribution--\n                                    ``(I) to an organization described \n                                in clauses (ii), (iii), (v), or (vi) of \n                                subparagraph (A), and\n                                    ``(II) which is designated for use \n                                in conducting medical research.\n                            ``(v) Medical research.--For purposes of \n                        this subparagraph, the term `medical research' \n                        has the meaning given such term under the \n                        regulations promulgated under subparagraph \n                        (A)(ii), as in effect on the date of the \n                        enactment of this subparagraph.''.\n    (b) Conforming Amendments.--\n            (1) Section 170(b)(1)(A) of the Internal Revenue Code of \n        1986 is amended in the matter preceding clause (i) by inserting \n        ``(other than a medical research contribution)'' after \n        ``contribution''.\n            (2) Section 170(b)(1)(B) of such Code is amended by \n        inserting ``or a medical research contribution'' after \n        ``applies''.\n            (3) Section 170(b)(1)(C)(i) of such Code is amended by \n        striking ``subparagraph (D)'' and inserting ``subparagraph (D) \n        or (G)''.\n            (4) Section 170(b)(1)(D)(i) of such Code is amended--\n                    (A) in the matter preceding subclause (I), by \n                inserting ``or a medical research contribution'' after \n                ``applies'', and\n                    (B) in the second sentence, by inserting ``(other \n                than medical research contributions)'' before the \n                period.\n    (c) Effective Date.--The amendments made by this section shall \napply--\n            (1) to contributions made in taxable years beginning after \n        December 31, 2001, and\n            (2) to contributions made on or before December 31, 2001, \n        but only to the extent that a deduction would be allowed under \n        section 170 of the Internal Revenue Code of 1986 for taxable \n        years beginning after December 31, 1999, had section \n        170(b)(1)(G) of such Code (as added by this section) applied to \n        such contributions when made.\n\nSEC. 3. TREATMENT OF CERTAIN INCENTIVE STOCK OPTIONS.\n\n    (a) AMT Adjustments.--Section 56(b)(3) of the Internal Revenue Code \nof 1986 (relating to treatment of incentive stock options) is amended--\n            (1) by striking ``Section 421'' and inserting the \n        following:\n                            ``(A) In general.--Except as provided in \n                        subparagraph (B), section 421'', and\n            (2) by adding at the end the following new subparagraph:\n                            ``(B) Exception for certain medical \n                        research stock.--\n                                    ``(i) In general.--This paragraph \n                                shall not apply in the case of a \n                                medical research stock transfer of \n                                stock acquired pursuant to the exercise \n                                of an incentive stock option occurring \n                                within the same taxable year as the \n                                exercise.\n                                    ``(ii) Medical research stock \n                                transfer.--For purposes of clause (i), \n                                the term `medical research stock \n                                transfer' means a transfer--\n                                            ``(I) of stock which is \n                                        traded on an established \n                                        securities market, and\n                                            ``(II) which is a medical \n                                        research contribution (as \n                                        defined in section \n                                        170(b)(1)(G)(iv)).''.\n    (b) Nonrecognition of Certain Incentive Stock Options.--Section \n422(c) of the Internal Revenue Code of 1986 (relating to special rules) \nis amended by adding at the end the following new paragraph:\n            ``(8) Medical research contributions.--For purposes of this \n        section and section 421, the transfer of a share of stock which \n        is a medical research stock transfer (as defined in section \n        56(b)(3)(B)) shall be treated as meeting the requirements of \n        subsection (a)(1).''.\n    (c) Effective Date.--The amendments made by this section shall \napply to transfers of stock made after the date of the enactment of \nthis Act."
}